Sources indicated that SEBI is leaning towards allowing a net end of the day limit of Rs 1,500 crore and a gross limit of Rs ...

Not everyone in crypto wants to be seen. As 2025 rolls on, the digital asset space is undergoing a quiet transformation. While mainstream exchanges chase regulation, fiat integration, and Wall Street ...

Google I/O 2025 -- is confirmed to kick off on May 20. Without revealing the intricate details, the tech giant has indicated ...

Dog Days for free on VPesports! This way you can join the adventure with our guide for easy access via Steam. Enjoy the ...

Iovance Therapeutics’ stock dropped more than 44% on Friday afternoon, a day after the company slashed its 2025 sales ...

Gate.io's latest Proof of Reserves report reveals $10.865B in total reserves, 128.6% reserve ratio, using zero-knowledge ...

When working remotely on broadcast and live event content, network predictability can be uncertain, introducing ... Read More ...

Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an appealing treatment for advanced melanoma.

Compass Therapeutics, Inc.’s CMPX share price has dipped by 5.62%, which has investors questioning if this is right time to buy.

A US commission of experts and legislators is discussing how to maintain AI's supremacy over China. More details here.

The scale of the campaign is reflected in the fact that over 38,000 distinct FreeDrain sub-domains hosting lure pages have ...

Binance leads centralized crypto exchanges with 38% market share despite a drop in April trading volume, says CoinGecko.